News

TCA Cellular Therapy said that the funding will help the company to continue the development of adult stem cell therapies for critical limb ischemia, cardiac ischemia, myocardial infarction,

Nutrition 21 has posted a net loss of $898,000 for the first quarter 2010, or $0.01 loss per diluted share, compared to net loss of $643,000, or $0.01

AGP’s generic drug manufacturing facility recently received inspection approvals by both the Food and Drug Board of Ghana (FDB) and the Ghana Standards Board (GSB). EWPI stated that

Oleptro extended release tablets are once-daily formulation of the antidepressant trazodone, for the treatment of major depressive disorder (MDD) in adults. Under the Drug Price Competition and Patent

ASCEND-HF study showed that Natrecor demonstrated no difference from placebo in the co-primary endpoints of dyspnea, measured at six and 24 hours, or in the composite of heart

Macugen, a selective inhibitor of VEGF-165, is approved for the treatment of neovascular age-related macular degeneration (neovascular AMD), which is expected to decrease the frequency of dosing from

Most recently, Kelly worked as the vice president and controller at MedImmune, and joined MedImmune as director of Sales and Marketing Finance and progressed to the role of

NovaDel Pharma’s loss from operations was $1.52m, compared to $1.28m for the comparable period in 2009. For the nine months ended 30 September 2010, NovaDel has posted a

Bohai Pharma has posted a net income of $3m for the first quarter 2010, or $0.15 per diluted share, compared to net income of $1.9m, or $0.15 per